Skip to main content
. 2022 Dec 1;14(23):5954. doi: 10.3390/cancers14235954
ALT alanine transaminase
APC antigen-presenting cells
AST aspartate transaminase
COVID-19 coronavirus disease 2019
CRRT continuous renal replacement therapy
CRP c-reactive protein
CTLA-4 T-lymphocyte-associated protein 4
ECOG Eastern Cooperative Oncology Group performance status
eGFR estimated glomerular filtration rate
GIST gastrointestinal stromal tumors
ICIs immune checkpoint inhibitors
ICU intensive care unit
IMT immunotherapy
irAE immune-related adverse event
LDH lactose dehydrogenase
MHC major histocompatibility complex
NA not performed
NSCLC non-small-cell lung cancer
NK natural killer cells
OS overall survival
PD-1 programmed cell death-1
PD-L1 programmed cell death Ligand 1
RCC renal cell carcinoma
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
TCR T-cell receptor
WBC white blood cell